Recherchiere Firmenbekanntmachungen und finanzielle Kennzahlen
EU-Förderung (12 Mio. €): Eine globale Allianz zur Bekämpfung und Prävention des Zika-Virus Hor01.10.2016 EU-Rahmenprogramm für Forschung und Innovation "Horizont"
Auf einen Blick
Text
Eine globale Allianz zur Bekämpfung und Prävention des Zika-Virus
"ZIKAlliance is a multidisciplinary project with a global ""One Health"" approach, built: on a multi-centric network of clinical cohorts in the Caribbean, Central & South America; research sites in countries where the virus has been or is currently circulating (Africa, Asia, Polynesia) or at risk for emergence (Reunion Island); a strong network of European and Brazilian clinical & basic research institutions; and multiple interfaces with other scientific and public health programmes. ZIKAlliance will addrees three key objectives relating to (i) impact of Zika virus (ZIKV) infection during pregnancy and short & medium term effects on newborns, (ii) associated natural history of ZIKV infection in humans and their environment in the context of other circulating arboviruses and (iii) building the overall capacity for preparedness research for future epidemic threats in Latin America & the Caribbean. The project will take advantage of large standardised clinical cohorts of pregnant women and febrile patients in regions of Latin America and the Caribbean were the virus is circulating, expanding a preexisting network established by the IDAMS EU project. I will also benefit of a very strong expertise in basic and environmental sciences, with access to both field work and sophisticated technological infrastructures to characterise virus replication and physiopathology mechanisms. To meet its 3 key objectives, the scientific project has been organised in 9 work packages, with WP2/3 dedicated to clinical research (cohorts, clinical biology, epidemiology & modeling), WP3/4 to basic research (virology & antivirals, pathophysiology & animal models), WP5/6 to environmental research (animal reservoirs, vectors & vector control) , WP7/8 to social sciences & communication, and WP9 to management. The broad consortium set-up allow gathering the necessary expertise for an actual interdisciplinary approach, and operating in a range of countries with contrasting ZIKV epidemiological status."
Geförderte Unternehmen:
| Firmenname | Förderungssumme |
| Academisch Ziekenhuis Groningen | 263.901 € |
| Academisch Ziekenhuis Leiden | 191.396 € |
| Agence Nationale de la Securite Sanitaire de L Alimentation de L Environnement et du Travail | 112.902 € |
| 87.983 € | |
| CHARITE - UNIVERSITAETSMEDIZIN BERLIN | 330.828 € |
| Centre National de la Recherche Scientifique Cnrs | 87.924 € |
| Centrum Voor Innovatie en Stimulatie Van Medicijnontwikkeling Leuven VZW | 0,00 € |
| Commissariat a L Energie Atomique et aux Energies Alternatives | 283.987 € |
| 0,00 € | |
| 73.729 € | |
| Erasmus Universitair Medisch Centrum Rotterdam | 624.108 € |
| 0,00 € | |
| Folkehelseinstituttet | 21.627 € |
| 75.572 € | |
| 42.481 € | |
| 216.750 € | |
| 735.691 € | |
| Inserm Transfert SA | 362.625 € |
| Institut Louis Malarde | 16.711,89 € |
| Institut National de la Sante et de la Recherche Medicale | 2.285.366 € |
| Institut Pasteur | 824.777 € |
| Institut Pasteur DE Dakar | 56.034 € |
| 29.492 € | |
| 56.034 € | |
| 0,00 € | |
| Institut de Recerca i Tecnologia Agroalimentaries | 49.153 € |
| Institut de Recherche Pour le Developpement | 212.929 € |
| 69.510 € | |
| 0,00 € | |
| Instituto Nacional DE Salud Publica | 0,00 € |
| Janssen Pharmaceutica N.V. | 55.089 € |
| Janssen-Cilag | 0,00 € |
| Katholieke Universiteit Leuven | 539.412 € |
| Laboratorio Nacional de Computacao Cientifica | 6.144,08 € |
| 374.174 € | |
| MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN e. V. | 0,00 € |
| OTTO-VON-GUERICKE-UNIVERSITAET MAGDEBURG | 261.492 € |
| STIFTUNG TIERAERZTLICHE HOCHSCHULE HANNOVER | 0,00 € |
| 177.103 € | |
| Stichting HET Nederlands Kanker Instituut-Antoni Van Leeuwenhoek Ziekenhuis | 78.398 € |
| The Chancellor, Masters and Scholars of the University of Oxford | 498.695 € |
| 100.610 € | |
| 0,00 € | |
| 102.360 € | |
| UNIVERSITATSKLINIKUM HEIDELBERG | 1.127.491 € |
| 328.002 € | |
| 133.701 € | |
| 0,00 € | |
| 221.187 € | |
| Universita Degli Studi DI Siena | 63.898 € |
| Universitat de Barcelona | 98.067 € |
| Universite Lyon 1 Claude Bernard | 98.067 € |
| 73.729 € | |
| Universite d'AIX Marseille | 129.722 € |
| Universite de Liege | 245.763 € |
| University of Glasgow | 95.356 € |
| 44.237 € |
Quelle: https://cordis.europa.eu/project/id/734548
Diese Bekanntmachung wurde von Englisch nach Deutsch übersetzt. Die Bekanntmachung bezieht sich auf einen vergangenen Zeitpunkt, und spiegelt nicht notwendigerweise den heutigen Stand wider.
Die Visualisierungen zu "Academisch Ziekenhuis Groningen - EU-Förderung (12 Mio. €): Eine globale Allianz zur Bekämpfung und Prävention des Zika-Virus"
werden von
North Data
zur Weiterverwendung unter einer
Creative Commons Lizenz
zur Verfügung gestellt.
